CD4+ T cells play a critical role in the generation of primary and memory antitumor immune responses elicited by SA-4-1BBL and TAA-based vaccines in mouse tumor models.
about
Survivin: a unique target for tumor therapy4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4+CD25+FoxP3+ T Regulatory Cell Suppression.Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients.SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccinesSA-4-1BBL/MPL as a novel immune adjuvant platform to combat cancerA tumor lysate is an effective vaccine antigen for the stimulation of CD4(+) T-cell function and subsequent induction of antitumor immunity mediated by CD8(+) T cells.Conditions for the generation of cytotoxic CD4(+) Th cells that enhance CD8(+) CTL-mediated tumor regression.Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy.Emerging strategies for cancer immunoprevention.Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.PKC-Theta is a Novel SC35 Splicing Factor Regulator in Response to T Cell ActivationSA-4-1BBL and monophosphoryl lipid A constitute an efficacious combination adjuvant for cancer vaccines.Current challenges for cancer vaccine adjuvant development.Current perspectives of SA-4-1BBL in immune modulation during cancer.Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer.
P2860
Q26747332-FC374894-2A8C-4AB3-96DC-17859CA9C7DCQ35980876-B5270742-61C7-47C3-A9D8-F45610AAC606Q36060333-0EBF048A-C1F2-4EAE-924A-C19B208B5223Q36487245-6087A59E-D404-49DD-B1B0-B178F39CBC07Q36597325-2D01C0A5-D341-496C-BB8A-E622066158ADQ36839001-F432FC04-6433-4957-BC63-5560B44C67DFQ37223717-5508D164-F7A0-471A-AC2C-E9A6C50CA732Q38284345-DE3E0EAA-63BF-4C04-9542-2FBDE0C4D5FDQ38585850-A5A9C227-A26B-4CBF-BBDD-6470BB7884C5Q39015659-CB302EBD-F870-41F3-93FE-BD394AEC43F0Q40900091-91B38A6D-AF64-41E1-BE5F-9479394BC8BBQ42186082-5B4F2AD3-EFAB-41D8-8747-B63AD82E896CQ48160317-B452E6B3-94C6-447F-9BF1-BC3FB41B195AQ49875788-B5D0C709-5E58-4E4C-BF74-4256BCC83486Q52746279-BF797799-57DD-4C74-A20F-C080E5D4FD61
P2860
CD4+ T cells play a critical role in the generation of primary and memory antitumor immune responses elicited by SA-4-1BBL and TAA-based vaccines in mouse tumor models.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
CD4+ T cells play a critical r ...... accines in mouse tumor models.
@ast
CD4+ T cells play a critical r ...... accines in mouse tumor models.
@en
CD4+ T cells play a critical r ...... accines in mouse tumor models.
@nl
type
label
CD4+ T cells play a critical r ...... accines in mouse tumor models.
@ast
CD4+ T cells play a critical r ...... accines in mouse tumor models.
@en
CD4+ T cells play a critical r ...... accines in mouse tumor models.
@nl
prefLabel
CD4+ T cells play a critical r ...... accines in mouse tumor models.
@ast
CD4+ T cells play a critical r ...... accines in mouse tumor models.
@en
CD4+ T cells play a critical r ...... accines in mouse tumor models.
@nl
P2093
P2860
P1433
P1476
CD4+ T cells play a critical r ...... accines in mouse tumor models.
@en
P2093
Abhishek K Srivastava
Esma S Yolcu
Haval Shirwan
Rajesh K Sharma
P2860
P304
P356
10.1371/JOURNAL.PONE.0073145
P407
P577
2013-09-16T00:00:00Z